A global epidemiological analysis found multiple myeloma burden has increased over the past three decades, with causal links including higher body mass index. At the same time, projections suggest future incidence rates may decline by 2035, indicating a divergence between observed historical growth and modeled forward trajectories. The study’s modeling approach ties the burden trend to modifiable risk factors, while the forecast component signals that population-level drivers could change over time. For payers and health systems, these findings can influence planning for screening, referral pathways, and treatment capacity. The combination of historical rise and changing forecast emphasizes the need to track risk-factor prevalence and healthcare access dynamics rather than relying on past growth alone.
Get the Daily Brief